Using a device to change how people cope with anxiety
Official title: Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
Run by Medical University of South Carolina · NCT04824105 · Data updated 2026-11-12
This study is testing if a device that uses magnetic pulses can help people with anxiety learn to cope better with their feelings.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | June 26, 2021 |
| Main results expected | August 31, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT04824105 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 who meet the criteria for an anxiety disorder and are currently seeking mental health treatment.
✕Probably not a fit
Patients with severe substance use disorders, psychotic disorders, or certain neurological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates whether repetitive transcranial magnetic stimulation (rTMS) can alter brain activity to improve coping mechanisms in individuals with anxiety disorders. Participants, aged 18 to 65, who are currently seeking treatment for anxiety will undergo three visits at the Medical University of South Carolina. The first visit includes interviews and tasks to assess anxiety while measuring brain activation, followed by two sessions of rTMS aimed at enhancing brain activity. After each rTMS session, participants will engage in tasks to evaluate their emotional responses.
Why it matters
Potential benefit: If successful, this approach could provide a novel treatment option for individuals struggling with anxiety disorders.
How similar studies have gone: Other studies using rTMS for anxiety have shown promising results, indicating potential effectiveness in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 - 65 y.o. * Meets criteria for an anxiety disorder (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Specific Phobia), posttraumatic stress disorder, obsessive- compulsive disorder, or current adjustment disorder with anxiety * Is currently seeking mental health treatment * Is able to read consent document and provide informed consent. * English is a first or primary fluent language. Exclusion Criteria: * Current alcohol or substance use disorder of more than mild severity (as defined by DSM-5 and determined using standardized self-report instruments) * Lifetime diagnosis of psychotic disorder or bipolar mania * Presence of neurological disorder that contraindicates TMS or neurophysiological recording: Seizure disorder Lifetime history of traumatic brain injury with loss of consciousness Neurodegenerative disorder (e.g., Alzheimer's Disease, Parkinson's Disease, Frontotemporal Dementia) * Presence of other medical disorder that would make it too uncomfortable to sit or lie still for long recording periods * Presence of standard contraindications for MRI or rTMS Metal in the body Currently pregnant Claustrophobia Significant sensitivity to noise Medical conditions or treatments that lower seizure threshold History of severe brain injury History of seizures/ epilepsy * Currently taking anticholinergic mediation, neuroleptic medication, or sedative/ hypnotic medication Note: SSRI, cholinesterase inhibitors or NMDA receptor antagonists are allowed if patient has been on a stable regimen of four weeks prior to enrollment * Currently taking chronic opiate medications or substances * Currently taking naltrexone
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Study coordinator: Christopher T Sege, PhD
- Email: sege@musc.edu
- Phone: 8437928465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
-
Does extra family income improve child mental health and brain biology in low-income families?
This study tests whether three years of extra income for parents can improve their child’s mental health and neuroimmune function.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
AI-guided cognitive behavioral therapy for depression and anxiety
This program will try an AI-guided online CBT to see if it helps adults with mild depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.